CA2030875C - Methodes et sondes pour le depistage de la nucleoside et methode de fabrication de ces sondes - Google Patents

Methodes et sondes pour le depistage de la nucleoside et methode de fabrication de ces sondes Download PDF

Info

Publication number: CA2030875C
Authority: CA; Canada
Prior art keywords: probe; moiety; accordance; reporter; fluorescein
Prior art date: 1990-11-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA 2030875

Other languages

English (en)

Other versions

CA2030875A1 (fr

Inventor

Alan R.P. Paterson

Carol E. Cass

Wendy P. Gati

James D. Craik

Morris J. Robins

James S. Wiley

Gary Jamieson

William H. Sawyer

John K. Buolamwini

David P. Mcadam

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Alberta

Original Assignee

University of Alberta

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-26

Filing date

1990-11-26

Publication date

2002-07-02

1990-11-26 Application filed by University of Alberta filed Critical University of Alberta

1990-11-26 Priority to CA 2030875 priority Critical patent/CA2030875C/fr

1992-05-27 Publication of CA2030875A1 publication Critical patent/CA2030875A1/fr

2002-07-02 Application granted granted Critical

2002-07-02 Publication of CA2030875C publication Critical patent/CA2030875C/fr

2010-11-26 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000000523 sample Substances 0.000 title claims abstract description 81
108091006527 nucleoside transporters Proteins 0.000 title claims abstract description 48
102000019055 Nucleoside Transport Proteins Human genes 0.000 title claims abstract description 47
238000000034 method Methods 0.000 title claims abstract description 32
238000004519 manufacturing process Methods 0.000 title claims description 3
150000001875 compounds Chemical class 0.000 claims abstract description 21
229910052736 halogen Inorganic materials 0.000 claims abstract description 20
150000002367 halogens Chemical class 0.000 claims abstract description 20
210000004102 animal cell Anatomy 0.000 claims abstract description 17
229910052799 carbon Inorganic materials 0.000 claims abstract description 15
229910052757 nitrogen Inorganic materials 0.000 claims abstract description 14
125000005647 linker group Chemical group 0.000 claims abstract description 13
210000005260 human cell Anatomy 0.000 claims abstract description 7
229910052717 sulfur Inorganic materials 0.000 claims abstract description 7
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims abstract description 5
125000000217 alkyl group Chemical group 0.000 claims abstract description 5
150000002373 hemiacetals Chemical class 0.000 claims abstract description 5
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 5
125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims abstract 6
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 3
210000004027 cell Anatomy 0.000 claims description 79
230000027455 binding Effects 0.000 claims description 49
OAFPVFZXWPVEBS-NVQRDWNXSA-N (2s,3s,4r,5r)-2-(2-aminoethylsulfanylmethyl)-5-[6-[(4-nitrophenyl)methylamino]purin-9-yl]oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CSCCN)O[C@H]1N1C2=NC=NC(NCC=3C=CC(=CC=3)[N+]([O-])=O)=C2N=C1 OAFPVFZXWPVEBS-NVQRDWNXSA-N 0.000 claims description 30
239000002777 nucleoside Substances 0.000 claims description 22
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical group O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 16
230000000694 effects Effects 0.000 claims description 14
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
230000002285 radioactive effect Effects 0.000 claims description 10
150000003839 salts Chemical class 0.000 claims description 8
125000003835 nucleoside group Chemical group 0.000 claims description 7
108090001008 Avidin Proteins 0.000 claims description 5
229960002685 biotin Drugs 0.000 claims description 5
235000020958 biotin Nutrition 0.000 claims description 5
239000011616 biotin Substances 0.000 claims description 5
238000010511 deprotection reaction Methods 0.000 claims description 5
229910052760 oxygen Inorganic materials 0.000 claims description 5
239000008194 pharmaceutical composition Substances 0.000 claims description 5
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 4
238000005804 alkylation reaction Methods 0.000 claims description 4
230000002401 inhibitory effect Effects 0.000 claims description 4
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 4
108010090804 Streptavidin Proteins 0.000 claims description 3
230000029936 alkylation Effects 0.000 claims description 3
238000006243 chemical reaction Methods 0.000 claims description 3
239000003153 chemical reaction reagent Substances 0.000 claims description 3
239000003937 drug carrier Substances 0.000 claims description 3
238000010438 heat treatment Methods 0.000 claims description 3
239000011325 microbead Substances 0.000 claims description 3
XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 claims description 3
108060006184 phycobiliprotein Proteins 0.000 claims description 3
230000008707 rearrangement Effects 0.000 claims description 3
239000011347 resin Substances 0.000 claims description 3
229920005989 resin Polymers 0.000 claims description 3
OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical group O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 claims description 2
DEQPBRIACBATHE-FXQIFTODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-2-iminopentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCC(=N)C(=O)O)SC[C@@H]21 DEQPBRIACBATHE-FXQIFTODSA-N 0.000 claims description 2
125000002252 acyl group Chemical group 0.000 claims description 2
239000000427 antigen Substances 0.000 claims description 2
108091007433 antigens Proteins 0.000 claims description 2
102000036639 antigens Human genes 0.000 claims description 2
FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 claims description 2
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 claims description 2
IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 claims description 2
FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 claims description 2
238000004255 ion exchange chromatography Methods 0.000 claims description 2
125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 claims description 2
238000002360 preparation method Methods 0.000 claims description 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims 2
XECCOMIMOJOGCO-WOUKDFQISA-N (2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-(2-hydroxyethylsulfanylmethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CSCCO)[C@@H](O)[C@H]1O XECCOMIMOJOGCO-WOUKDFQISA-N 0.000 claims 1
CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 claims 1
CJLZKWCFKKBJGA-BMWKMAGWSA-N 2-[2-[[(2s,3s,4r,5r)-3,4-dihydroxy-5-[6-[(4-nitrophenyl)methylamino]purin-9-yl]oxolan-2-yl]methylsulfanyl]ethyl]isoindole-1,3-dione Chemical compound N1=CN=C2N([C@@H]3O[C@H](CSCCN4C(C5=CC=CC=C5C4=O)=O)[C@H]([C@H]3O)O)C=NC2=C1NCC1=CC=C([N+]([O-])=O)C=C1 CJLZKWCFKKBJGA-BMWKMAGWSA-N 0.000 claims 1
229920000936 Agarose Polymers 0.000 claims 1
241001367053 Autographa gamma Species 0.000 claims 1
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims 1
229920001577 copolymer Chemical group 0.000 claims 1
235000001671 coumarin Nutrition 0.000 claims 1
150000004775 coumarins Chemical class 0.000 claims 1
102000040811 transporter activity Human genes 0.000 claims 1
108091092194 transporter activity Proteins 0.000 claims 1
125000001072 heteroaryl group Chemical group 0.000 abstract description 5
150000001241 acetals Chemical class 0.000 abstract description 3
125000001931 aliphatic group Chemical group 0.000 abstract description 3
150000004945 aromatic hydrocarbons Chemical class 0.000 abstract description 3
125000003118 aryl group Chemical group 0.000 abstract description 3
125000004404 heteroalkyl group Chemical group 0.000 abstract description 3
150000002390 heteroarenes Chemical class 0.000 abstract description 3
125000000623 heterocyclic group Chemical group 0.000 abstract description 3
125000003107 substituted aryl group Chemical group 0.000 abstract description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 73
DYCJFJRCWPVDHY-LSCFUAHRSA-N NBMPR Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(SCC=3C=CC(=CC=3)[N+]([O-])=O)=C2N=C1 DYCJFJRCWPVDHY-LSCFUAHRSA-N 0.000 description 54
108010078791 Carrier Proteins Proteins 0.000 description 15
239000000203 mixture Substances 0.000 description 15
101100002068 Bacillus subtilis (strain 168) araR gene Proteins 0.000 description 13
101150044616 araC gene Proteins 0.000 description 13
150000003833 nucleoside derivatives Chemical class 0.000 description 13
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
239000002609 medium Substances 0.000 description 9
238000000684 flow cytometry Methods 0.000 description 8
230000005764 inhibitory process Effects 0.000 description 8
230000008569 process Effects 0.000 description 8
239000000243 solution Substances 0.000 description 8
-1 thiol salts Chemical class 0.000 description 8
QVZCXCJXTMIDME-UHFFFAOYSA-N Biopropazepan Trimethoxybenzoate Chemical compound COC1=C(OC)C(OC)=CC(C(=O)OCCCN2CCN(CCCOC(=O)C=3C=C(OC)C(OC)=C(OC)C=3)CCC2)=C1 QVZCXCJXTMIDME-UHFFFAOYSA-N 0.000 description 7
238000003556 assay Methods 0.000 description 7
229960001079 dilazep Drugs 0.000 description 7
238000002143 fast-atom bombardment mass spectrum Methods 0.000 description 7
230000009871 nonspecific binding Effects 0.000 description 7
238000010186 staining Methods 0.000 description 7
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
239000003446 ligand Substances 0.000 description 6
238000005259 measurement Methods 0.000 description 6
239000007787 solid Substances 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
101100073357 Streptomyces halstedii sch2 gene Proteins 0.000 description 5
238000011534 incubation Methods 0.000 description 5
230000004941 influx Effects 0.000 description 5
239000000047 product Substances 0.000 description 5
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
238000005481 NMR spectroscopy Methods 0.000 description 4
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
150000001412 amines Chemical class 0.000 description 4
239000012312 sodium hydride Substances 0.000 description 4
229910000104 sodium hydride Inorganic materials 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
VOLRSQPSJGXRNJ-UHFFFAOYSA-N 4-nitrobenzyl bromide Chemical compound [O-][N+](=O)C1=CC=C(CBr)C=C1 VOLRSQPSJGXRNJ-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
238000001514 detection method Methods 0.000 description 3
238000006073 displacement reaction Methods 0.000 description 3
210000003743 erythrocyte Anatomy 0.000 description 3
238000003818 flash chromatography Methods 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
230000003993 interaction Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
CPYCKNMORRXMPZ-BDWBDYAHSA-N n-[6-[2-[[(2s,3s,4r,5r)-3,4-dihydroxy-5-[6-[(4-nitrophenyl)methylamino]purin-9-yl]oxolan-2-yl]methylsulfanyl]ethylamino]-6-oxohexyl]-3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-carboxamide Chemical compound N1=CN=C2N([C@@H]3O[C@H](CSCCNC(=O)CCCCCNC(=O)C=4C=C5C(C6(C7=CC=C(O)C=C7OC7=CC(O)=CC=C76)OC5=O)=CC=4)[C@H]([C@H]3O)O)C=NC2=C1NCC1=CC=C([N+]([O-])=O)C=C1 CPYCKNMORRXMPZ-BDWBDYAHSA-N 0.000 description 3
239000008363 phosphate buffer Substances 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
238000001228 spectrum Methods 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
238000012360 testing method Methods 0.000 description 3
238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
238000005160 1H NMR spectroscopy Methods 0.000 description 2
IYSNPOMTKFZDHZ-KQYNXXCUSA-N 5'-chloro-5'-deoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CCl)[C@@H](O)[C@H]1O IYSNPOMTKFZDHZ-KQYNXXCUSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
208000007093 Leukemia L1210 Diseases 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
229910052786 argon Inorganic materials 0.000 description 2
239000007975 buffered saline Substances 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
239000013078 crystal Substances 0.000 description 2
UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 2
125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
230000005284 excitation Effects 0.000 description 2
238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
238000005567 liquid scintillation counting Methods 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
239000012528 membrane Substances 0.000 description 2
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
239000008188 pellet Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
229910052711 selenium Inorganic materials 0.000 description 2
239000012064 sodium phosphate buffer Substances 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
DKVZUGNICGXNBN-IWCJZZDYSA-N (2r,3r,4s,5r)-2-[6-[(2-hydroxy-3-iodo-5-nitrophenyl)methylsulfanyl]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(SCC=3C(=C(I)C=C(C=3)[N+]([O-])=O)O)=C2N=C1 DKVZUGNICGXNBN-IWCJZZDYSA-N 0.000 description 1
VAQMNFPQRLLRMG-LSCFUAHRSA-N (2r,3s,4r,5r)-2-(hydroxymethyl)-5-[6-[(4-nitrophenyl)methylamino]purin-9-yl]oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C=CC(=CC=3)[N+]([O-])=O)=C2N=C1 VAQMNFPQRLLRMG-LSCFUAHRSA-N 0.000 description 1
APAPOJUCRZTCHD-WOUKDFQISA-N (2s,3s,4r,5r)-2-(2-aminoethylsulfanylmethyl)-5-(6-aminopurin-9-yl)oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CSCCN)O[C@H]1N1C2=NC=NC(N)=C2N=C1 APAPOJUCRZTCHD-WOUKDFQISA-N 0.000 description 1
MMFKGCWXPRJUPM-NVQRDWNXSA-N (2s,3s,4r,5r)-2-(2-hydroxyethylsulfanylmethyl)-5-[6-[(4-nitrophenyl)methylamino]purin-9-yl]oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CSCCO)O[C@H]1N1C2=NC=NC(NCC=3C=CC(=CC=3)[N+]([O-])=O)=C2N=C1 MMFKGCWXPRJUPM-NVQRDWNXSA-N 0.000 description 1
CQYYGCVORGQMEQ-UHFFFAOYSA-N 2,5-dioxopyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1C(=O)CCC1=O CQYYGCVORGQMEQ-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
101150041968 CDC13 gene Proteins 0.000 description 1
241001480079 Corymbia calophylla Species 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
206010056740 Genital discharge Diseases 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
229910004373 HOAc Inorganic materials 0.000 description 1
101000610640 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3 Proteins 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229920001410 Microfiber Polymers 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
101001110823 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A Proteins 0.000 description 1
101000712176 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B Proteins 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
241000282887 Suidae Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
102100040374 U4/U6 small nuclear ribonucleoprotein Prp3 Human genes 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
238000000862 absorption spectrum Methods 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
235000012538 ammonium bicarbonate Nutrition 0.000 description 1
239000001099 ammonium carbonate Substances 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
150000008209 arabinosides Chemical class 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
244000309466 calf Species 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
230000000536 complexating effect Effects 0.000 description 1
229940125782 compound 2 Drugs 0.000 description 1
238000004590 computer program Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012937 correction Methods 0.000 description 1
150000001893 coumarin derivatives Chemical class 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
210000003989 endothelium vascular Anatomy 0.000 description 1
DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
GTQFZXYECNSNNC-UHFFFAOYSA-N fluorescein 6-isothiocyanate Chemical compound O1C(=O)C2=CC=C(N=C=S)C=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GTQFZXYECNSNNC-UHFFFAOYSA-N 0.000 description 1
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical group [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
239000008103 glucose Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000002955 isolation Methods 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
239000003658 microfiber Substances 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
229910000403 monosodium phosphate Inorganic materials 0.000 description 1
230000010807 negative regulation of binding Effects 0.000 description 1
SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
102000037831 nucleoside transporters Human genes 0.000 description 1
125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
150000003138 primary alcohols Chemical class 0.000 description 1
238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000012264 purified product Substances 0.000 description 1
239000002212 purine nucleoside Substances 0.000 description 1
239000002718 pyrimidine nucleoside Substances 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000010992 reflux Methods 0.000 description 1
RWWYLEGWBNMMLJ-YSOARWBDSA-N remdesivir Chemical compound NC1=NC=NN2C1=CC=C2[C@]1([C@@H]([C@@H]([C@H](O1)CO[P@](=O)(OC1=CC=CC=C1)N[C@H](C(=O)OCC(CC)CC)C)O)O)C#N RWWYLEGWBNMMLJ-YSOARWBDSA-N 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
238000002211 ultraviolet spectrum Methods 0.000 description 1
238000003828 vacuum filtration Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA 2030875 1990-11-26 1990-11-26 Methodes et sondes pour le depistage de la nucleoside et methode de fabrication de ces sondes Expired - Fee Related CA2030875C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA 2030875 CA2030875C (fr)	1990-11-26	1990-11-26	Methodes et sondes pour le depistage de la nucleoside et methode de fabrication de ces sondes

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA 2030875 CA2030875C (fr)	1990-11-26	1990-11-26	Methodes et sondes pour le depistage de la nucleoside et methode de fabrication de ces sondes

Publications (2)

Publication Number	Publication Date
CA2030875A1 CA2030875A1 (fr)	1992-05-27
CA2030875C true CA2030875C (fr)	2002-07-02

Family

ID=4146531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2030875 Expired - Fee Related CA2030875C (fr)	1990-11-26	1990-11-26	Methodes et sondes pour le depistage de la nucleoside et methode de fabrication de ces sondes

Country Status (1)

Country	Link
CA (1)	CA2030875C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2771011A4 (fr)	2011-10-24	2015-04-15	Glaxosmithkline Ip No 2 Ltd	Composés chimiques
KR20190017030A (ko)	2016-06-13	2019-02-19	글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드	Dnmt1의 억제제로서의 치환된 피리딘

1990
- 1990-11-26 CA CA 2030875 patent/CA2030875C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2030875A1 (fr)	1992-05-27

Publication	Publication Date	Title
Steiner et al.	1972	Radioimmunoassay for cyclic nucleotides: I. Preparation of antibodies and iodinated cyclic nucleotides
DE3750503T2 (de)	1995-02-09	Chemilumineszierende Acridinium- und Phenantridiniumsalze.
DE3650103T2 (de)	1995-03-30	Nukleinsäure-Sandwichassay in Lösungsphase und dafür geeignete Polynukleotidprobe.
JP2781378B2 (ja)	1998-07-30	レポーター標識鎖ターミネーター
US20200385389A1 (en)	2020-12-10	Small-molecule hsp90 inhibitors
JP4435305B2 (ja)	2010-03-17	トピラメートのイムノアッセイ、並びに類似体及び抗体
CN104640933A (zh)	2015-05-20	荧光pH敏感性染料和其使用方法
US20080009018A1 (en)	2008-01-10	Immunoassays for topiramate
EP1095274A1 (fr)	2001-05-02	Reactif trifonctionnel pour la conjugaison avec une biomolecule
JP2009108098A (ja)	2009-05-21	蛍光標識としてのスルホン化ジアリールローダミン色素
Cristalli et al.	1993	Identification of a receptor for ADP on blood platelets by photoaffinity labelling
US5248770A (en)	1993-09-28	Molecular probes for adenosine receptors
JPH04503059A (ja)	1992-06-04	５′―ビオチン化オリゴヌクレオチド製造用の試剤
PH26672A (en)	1992-09-15	2-(substituted amino) adenosines as antihypertensives
USRE35904E (en)	1998-09-22	Method and probes for detecting nucleoside transporter and method for producing the probes
CA2030875C (fr)	2002-07-02	Methodes et sondes pour le depistage de la nucleoside et methode de fabrication de ces sondes
ES2392900T3 (es)	2012-12-14	Ésteres de acridinio estables con emisión de luz rápida
Kumar et al.	1996	Separation of 7-methyl-and 7-(2-hydroxyethyl)-guanine adducts in human DNA samples using a combination of TLC and HPLC
US6455322B1 (en)	2002-09-24	Competition binding assay for detecting P2YADP receptor ligands
CA2586474A1 (fr)	2006-05-04	Analogues de lamotrigine
JPS5823699A (ja)	1983-02-12	新規なイソシアネ−ト
Buolamwini et al.	1994	Conjugates of Fluorescein and Saenta (5′-S-(2-Aminoethyl)-N 6-(4-nitrobenzyl)-5′-thioadenosine): Flow Cytometry Probes for the ES Nucleoside Transporter Elements of the Plasma Membrane
US5053336A (en)	1991-10-01	Monoclonal antibodies for the separate detection of halodeoxyuridines and method for their use
CA1339130C (fr)	1997-07-29	Marqueurs pour la detection de l'hypoxemie
US20010023288A1 (en)	2001-09-20	Trifunctional reagent for conjugation to a biomolecule

Legal Events

Date	Code	Title	Description
1997-11-06	EEER	Examination request
2006-11-27	MKLA	Lapsed